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Mycobacterium tuberculosis Beijing
Lineage and Risk for Tuberculosis
in Child Household Contacts, Peru
Chuan-Chin Huang,1 Alexander L. Chu,1 Mercedes C. Becerra, Jerome T. Galea,
Roger Calderón, Carmen Contreras, Rosa Yataco, Zibiao Zhang, Leonid Lecca, Megan B. Murray

Few studies have prospectively compared the relative
transmissibility and propensity to cause disease of Mycobacterium tuberculosis Beijing strains with other human-adapted strains of the M. tuberculosis complex. We
assessed the effect of Beijing strains on the risk for M.
tuberculosis infection and disease progression in 9,151
household contacts of 2,223 culture-positive pulmonary
tuberculosis (TB) patients in Lima, Peru. Child contacts
exposed to Beijing strains were more likely than child
contacts exposed to non-Beijing strains to be infected at
baseline, by 12 months of follow-up, and during followup. We noted an increased but nonsignificant tendency
for child contacts to develop TB. Beijing strains were not
associated with TB in adult contacts. These findings suggest that Beijing strains are more transmissible in children than are non-Beijing strains.

T

uberculosis (TB) remains the leading cause of
death worldwide from a single infectious disease;
in 2017, ≈10 million incident cases and 1.7 million
deaths were reported (1). The causative pathogen,
Mycobacterium tuberculosis, is divided into 7 humanadapted phylogenetic lineages, of which some are
geographically restricted and others are widespread
throughout the world, possibly because they are better adapted to environments of high human density
(2). One of the widespread groups, lineage 2, includes
a widely distributed genotype, the Beijing strain, that
has been repeatedly implicated in outbreaks and in
the evolution of drug resistance (3–6). The global
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distribution of Beijing strains and their precipitous
rise in some populations have led researchers to speculate that it may be more transmissible and more likely to cause disease than other less widely distributed
M. tuberculosis lineages (7–9).
However, the few direct assessments of the relative
transmissibility of Beijing strains have been inconclusive. Although some studies found that exposure to
Beijing strains was more likely than exposure to other
strains to lead to TB (10–15), others reported no difference (16,17). Several studies have suggested that the
Beijing genotype is more common among young persons and that its frequency declines with age (18–21).
To explore these factors, we directly compared the relative transmissibility and propensity to cause disease of
Beijing strains with other strains in a cohort study of
household contacts of patients with pulmonary TB in
Lima, Peru.
Methods
Ethics Statement

The Institutional Review Board of Harvard School
of Public Health and the Research Ethics Committee
of the National Institute of Health of Peru approved
the study. All study participants or their guardians
provided written informed consent, and children <18
years of age provided assent.
Setting, Study Design, and Participant
Recruitment and Follow-Up

The study design and methods were previously described in detail (22). In brief, we conducted a prospective cohort study of household contacts of pulmonary TB patients in Lima, Peru. The study area
comprised 20 districts inhabited by ≈3.3 million residents living in urban areas and in periurban, informal
shantytown settlements.
1
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During September 2009–August 2012, we identified patients >15 years of age who had received a
diagnosis of clinically presumptive pulmonary TB at
any of 106 participating health centers. We confirmed
the microbiological status of their disease with either
a positive sputum smear or mycobacterial culture. We
also recorded the index patient’s sociodemographic
data; baseline smear status; presence or absence of
cavitary disease; tobacco and alcohol use; HIV status;
time from symptom onset until initiation of treatment; and, for patients, with drug-resistant TB, the
time from TB diagnosis until start of an effective treatment (i.e., a drug regimen deemed appropriate for the
index patient’s drug-resistant profile).
Within 2 weeks after index patient diagnosis, we
enrolled all consenting household contacts. We assessed baseline M. tuberculosis infection status with
the tuberculin skin test (TST) in household contacts
with no history of a positive TST or TB. Household
contacts who had signs or symptoms of TB underwent clinical evaluation and, if indicated, initiated
treatment under Peru’s National Tuberculosis Program guidelines (23). We offered HIV testing to all
study participants. In accordance with Peru’s National Tuberculosis Program guidelines, isoniazid
preventive therapy (IPT) was offered to household
contacts <19 years of age and persons with specified concurrent conditions. At the time of household
contact enrollment, we collected age, sex, sociodemographic, and occupational information; height
and weight; alcohol and tobacco use information;
HIV status; self-reported diabetes mellitus; history
and presence of M. bovis BCG vaccination scars; use
of IPT; history of TB; and housing features. We repeated the TST 6 and 12 months after initial evaluation among household contacts who had previously tested negative; 2, 6, and 12 months after initial
evaluation, we reevaluated them for pulmonary and
extrapulmonary TB. We also accessed the medical
records of health centers in the catchment areas to
identify household contacts whose TB was diagnosed at a health center during the follow-up period.
Whole-Genome Sequencing

Among 3,027 index patients with culture-positive
isolates at baseline, 2,143 had isolates that also underwent whole-genome sequencing (WGS) using
the Illumina HiSeq 4000 platform (Illumina, https://
www.illumina.com) with a read length of 100–150 bp
and >50-fold coverage. The raw sequence data were
trimmed using the sickle package (24) and mapped
to the H37Rv reference genome using the BWA-MEM
algorithm (25). We used a coverage-based approach,

Table 1. Baseline characteristics of Mycobacterium tuberculosis
culture-positive index patients, Lima, Peru, September 2009–
August 2012
Variable
No. (%), N = 2,223*
Age, y
16–30
1,363 (61)
31–45
465 (21)
>46
395 (18)
Sex
M
1,289 (58)
F
934 (42)
Concurrent condition
HIV seropositive
59 (3)
Self-reported diabetes
111 (6)
Current smoker
60 (3)
M. tuberculosis lineage
L2 (Beijing)
255 (12)
L4.1
951 (43)
L4.3
775 (35)
Other
242 (11)
Sputum smear status†
Negative
548 (25)
+
639 (29)
++
431 (19)
+++
596 (27)
Cavitary disease
655 (30)
Drug resistance profile
Pansusceptible
1,442 (67)
Resistant
726 (33)
*Numbers might not add to total because of missing data.
†+, 1–99 acid-fast bacilli (AFB) in 100 observed fields; ++, 1–10 AFB per
field in 50 observed fields; +++, >10 AFB per field in 20 observed fields.

specifically SAMtools (default settings) (26) and pilon (27), to identify single-nucleotide polymorphisms
across the whole genome. We assigned a call as missing if the valid depth of coverage at a specific site was
<8 reads, if the mean read-mapping quality at the site
did not reach 9, or if none of the alternative alleles accounted for >85% of the valid coverage.
Lineage Identification of M. tuberculosis Strains

Among index patients for whom WGS data were available, we identified M. tuberculosis lineages and sublineages on the basis of a previously published barcode
that differentiates the groups on the basis of singlenucleotide polymorphisms (28). For index patients
without available WGS data, we genotyped their M.
tuberculosis isolates using 24-locus mycobacterial interspersed repetitive units–variable-number tandem
repeats (MIRU-VNTR) (29). We used the best-match
algorithm from the MIRU-VNTRplus online database
(http://www.miru-vntrplus.org) to identify the lineages of the typed samples by cross-referencing them
with reference lineages stored on the database (30).
Outcomes

We considered 4 distinct outcomes: M. tuberculosis infection at baseline, time to TST conversion during the
12 months of follow-up, M. tuberculosis infection by

Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 26, No. 3, March 2020

569

RESEARCH

Table 2. Baseline characteristics of household contacts exposed to a Mycobacterium tuberculosis culture-positive index tuberculosis
patient, Lima, Peru, September 2009–August 2012
Variable
Total no. (%), N = 9,151*
Age <15 y, no. (%)
Age >15 y, no. (%)
Age, y
<15
3,225 (35)
3,225 (100)
Not applicable
>15
5,926 (65)
Not applicable
5,926 (100)
Sex
M
4,147 (45)
1,620 (50)
2,527 (43)
F
5,004 (55)
1,605 (50)
3,399 (53)
Concurrent condition
HIV seropositive
33 (<1)
3 (<1)
30 (1)
Self-reported diabetes
165 (2)
2 (<1)
163 (3)
Current smoker
559 (6)
4 (<1)
555 (10)
M. tuberculosis lineage exposure
L2 (Beijing)
1,041 (11)
349 (11)
692 (12)
L4.1
3,733 (41)
1,332 (41)
2,401 (41)
L4.3
3,416 (37)
1,202 (37)
2,214 (37)
Other
961 (11)
342 (11)
619 (10)
Presence of M. bovis BCG vaccination scar
8,110 (89)
2,876 (89)
5,253 (89)
Nutritional status
Normal weight
5,261 (58)
2,527 (79)
2,734 (47)
Underweight
163 (2)
95 (3)
68 (1)
Overweight
3,636 (40)
565 (18)
3,071 (52)
Socioeconomic status
Low
3,112 (35)
1,253 (40)
1,859 (33)
Middle
3,991 (45)
1,384 (44)
2,607 (45)
High
1,828 (21)
514 (16)
1,314 (23)
Isoniazid preventive therapy recipient
2,090 (23)
1,542 (48)
490 (7)
*Numbers might not add to total because of missing data.

12 months of follow-up, and incident disease during
the 12-month follow-up time. We classified household contacts as infected at baseline if they reported
a history of TB, reported a previous positive TST result within 6 months after study enrollment, or had
a positive TST (induration size >10 mm [>5 mm for
HIV-positive household contacts]) at baseline. We
considered initially TST-negative household contacts
to have undergone TST conversion if their TST status
converted from negative to positive or if TB developed
during follow-up. We considered household contacts
to be infected with M. tuberculosis by 12 months of
follow-up if contacts were infected at baseline or had
a TST conversion during the 12-month follow-up period (22). We considered household contacts to have
co-prevalent TB if it was diagnosed within 2 weeks
after the diagnosis in the index patient. If household
contacts received diagnoses 2 weeks–15 months (1year follow-up plus a 3-month buffer period) after
index patient diagnosis, we considered incident TB to

have developed in those contacts during follow-up.
We based TB diagnosis among contacts >18 years of
age on the same criteria we used for index patients;
the diagnosis among household contacts <18 years
was based on published consensus guidelines from
an expert panel on classifying TB in children (31).
Statistical Analysis

We made an a priori decision to analyze child household contacts (<15 years) and adult household contacts (>15 years) separately for several reasons. First,
we considered child contacts to be a more representative age group for household-based TB transmission than their more mobile, socially active adult
counterparts. Second, several previous studies suggest that Beijing strains more commonly affect children than adults (18–20). We used complete data
analyses in all multivariate adjustment models and
conducted all statistical analyses in R version 3.5.1
(https://www.r-project.org).

Table 3. Effect of the Mycobacterium tuberculosis Beijing lineage on the risk for infection at baseline in child and adult household
contacts of culture-positive index patients, Lima, Peru, September 2009–August 2012
Age <15 y, n = 3,115*
Age >15 y, n = 5,663*
Risk ratio (95% CI)
Risk ratio (95% CI)
Prevalence,
Prevalence,
Lineage
no. (%)†
Univariate
Multivariate‡
no. (%)†
Univariate
Multivariate‡
Non-Beijing
731 (26)
Referent
Referent
2,654 (53)
Referent
Referent
Beijing
110 (33)
1.27 (1.06–1.53)
1.23 (1.02–1.50)
353 (53)
0.99 (0.91–1.08) 1.00 (0.91–1.09)

*Likelihood ratio test for the interaction between age (<15 or >15) and index patient M. tuberculosis lineage: p = 0.025.
†Prevalence of baseline M. tuberculosis infection in the univariate model.
‡Multivariate model adjusted for index patient drug resistance profile; index patient age (16–30, 31–45, 46–60, and >60 y); index patient HIV status;
household contact age (0–5, 6–10, 11–15, 16–30, 31–45, 46–60, and >60 y); household contact M. bovis BCG vaccination status; household contact
socioeconomic status; household contact nutritional status.
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Table 4. Effect of the Mycobacterium tuberculosis Beijing lineage on the risk for infection by 12 months of follow-up in child and adult
household contacts of culture-positive index patients, Lima, Peru, September 2009–August 2012
Age <15 y, n = 2,521*
Age >15 y, n = 4,921*
Risk ratio (95% CI)
Risk ratio (95% CI)
Prevalence,
Prevalence,
Lineage
no. (%)†
Univariate
Multivariate‡
no. (%)†
Univariate
Multivariate‡
Non-Beijing
1,098 (49)
Referent
Referent
3,546 (82)
Referent
Referent
Beijing
173 (59)
1.20 (1.08–1.35)
1.22 (1.09–1.38)
474 (82)
1.00 (0.96–1.05) 1.01 (0.97–1.06)
*Likelihood ratio test for the interaction between age (<15 or >15 y) and index patient M. tuberculosis lineage: p = 0.003.
†Prevalence of M. tuberculosis infection by 12 months for the univariate model.
‡Adjusted for index patient drug resistance profile; index patient age (16–30, 31–45, 46–60, and >60 y); index patient HIV status; household contact age
(0–5, 6–10, 11–15, 16–30, 31–45, 46–60, and >60 y); household contact M. bovis BCG vaccination status; household contact socioeconomic status;
household contact nutritional status.

TB at Baseline and by 12 Months of Follow-Up

We used a modified Poisson generalized estimating
equation to measure the association between exposure to index patients infected with Beijing strains
and the likelihood of infection at baseline and by
12-months of follow-up. To account for correlation
within households, we specified an exchangeable
working correlation structure for observations within
the same household and obtained empirical SE estimates for robust inference. We constructed univariate and multivariate models to compare the effect of
exposure to Beijing and non-Beijing strains on the risk
for TB infection at baseline and at 12 months. In the
multivariate models, we included covariates from
index patients (age, drug resistance profile, and HIV
status) and their household contacts (age, diabetes
status, BCG vaccination status, socioeconomic status, and nutritional status). We conducted sensitivity
analyses in which we excluded household contacts
who reported a history of TB, a previous positive TST
result within 6 months after study enrollment, or a
history of receiving TB treatment.
Time to TST Conversion and to Incident Disease

We assessed the time to TST conversion among household contacts who were uninfected at baseline by defining the date of infection as the midpoint between the
date of enrollment and the date of a first positive TST result or TB diagnosis. We excluded from analysis household contacts who remained TST negative at the date
of their last TST result. For the time to TB analysis, we
excluded household contacts with co-prevalent TB and
excluded from analysis household contacts in whom TB

had not been diagnosed by the time of their death or at
the end of the study. We first plotted Kaplan-Meier survival curves to visually evaluate the association between
the index patient’s M. tuberculosis genotype and the 2
time-to-event outcomes. We then used Cox frailty proportional hazards model to evaluate risk factors for time
to TST conversion and time to incident disease while
accounting for clustering within households. We constructed univariate and multivariate models to compare
the effect of exposure to Beijing and non-Beijing strains
on the risk for TST conversion and incident disease during follow-up. In the multivariate models, we included
covariates from index patients (age, drug resistance profile, and HIV status) and their household contacts (age,
diabetes status, BCG vaccination status, socioeconomic
status, and nutritional status). We further adjusted for
the use of IPT and TB history in the multivariate model
of the time to incident disease analyses. We verified the
proportional hazards assumptions for each covariate by
including an interaction term for the covariate and time
and stratifying by covariates for which the assumption
did not hold. We conducted 2 sensitivity analyses, 1 in
which we defined TST conversion using an increment
of >6-mm induration size in repeat TST measurements
during follow-up and 1 in which we restricted the analysis to household contacts in whom active TB developed
during follow-up and who received their diagnoses
within >30 days after index patient enrollment.
Effect of Index Patient M. tuberculosis Lineage on
Protective Efficacy of BCG Vaccination

We also considered the possibility that index patient
M. tuberculosis lineage might modify the protective

Table 5. Hazard ratios of tuberculin skin test conversion comparing contacts exposed to a Mycobacterium tuberculosis Beijing lineage
with those exposed to a non-Beijing lineage, Lima, Peru, September 2009–August 2012
Age <15 y*
Age >15 y*
Hazard ratio (95% CI)
Hazard ratio (95% CI)
Lineage
Incidence, %†
Univariate
Multivariate‡
Incidence, %†
Univariate
Multivariate‡
Non-Beijing
0.26 (356/1,396)
Referent
Referent
0.69 (845/1,236)
Referent
Referent
Beijing
0.39 (62/160)
1.53 (1.09–2.14) 1.65 (1.17–2.33)
0.73 (118/162)
1.02 (0.80–1.30) 1.03 (0.80–1.33)
*Likelihood ratio test for the interaction between age (<15 or >15 y) and index patient M. tuberculosis lineage: p = 0.048.
†Per person-year for the univariate model.
‡Adjusted for index patient drug resistance profile; index patient age (16–30, 31–45, 46–60, and >60 y); index patient HIV status; household contact age
(0–5, 6–10, 11–15, 16–30, 31–45, 46–60, and >60 y); household contact M. bovis BCG vaccination status; household contact socioeconomic status;
household contact nutritional status.
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Table 6. Hazard ratios of incident tuberculosis among contacts exposed to a Mycobacterium tuberculosis Beijing lineage and a nonBeijing lineage, Lima, Peru, September 2009–August 2012
Age <15 y*
Age >15 y*
Hazard ratio (95% CI)
Hazard ratio (95% CI)
Lineage
Incidence, %†
Univariate
Multivariate‡
Incidence, %†
Univariate
Multivariate‡
Non-Beijing
3,043 (84/2,760)
Referent
Referent
2,874 (156/4,993)
Referent
Referent
Beijing
4,478 (15/335)
1.42 (0.78–2.59) 1.45 (0.77–2.72)
3,124 (19/661)
0.93 (0.57–1.52) 1.06 (0.64–1.77)
*Likelihood ratio test for the interaction between age (<15 or >15 y) and index patient M. tuberculosis lineage: p = 0.231.
†Per 100,000 person-years in the univariate model.
‡Adjusted for index patient drug resistance profile; index patient age (16–30, 31–45, 46–60, and >60 y); index patient HIV status; household contact age
(0–5, 6–10, 11–15, 16–30, 31–45, 46–60, and >60 y); household contact M. bovis BCG vaccination status; household contact SES; household contact
nutritional status; household contact use of isoniazid preventive therapy; household contact TB history.

efficacy of BCG vaccine. To examine whether index
patient M. tuberculosis strain type modified the association between BCG vaccination and outcomes of our
study, we added in our model an interaction term that
included index patient M. tuberculosis lineage and the
BCG vaccination status of household contacts.
Results
We enrolled 9,151 household contacts of 2,223 culture-positive pulmonary TB index patients. The study
enrollment rates were 85.5% for index patients and
94.6% for their household contacts. The retention
rates for enrolled household contacts were 92.0% at
6 months and 94.7% at 12 months of follow-up. At
baseline, 841 (27.0%) of 3,115 child household contacts and 3,007 (53.1%) of 5,663 adult household contacts were infected. A total of 951 (43%) index patients
had lineage 4.1 strain isolates, 775 (35%) had lineage
4.3 strain isolates, 255 (12%) had lineage 2 isolates (all
of which were of the Beijing strain), and 242 (11%)
had other strain isolates (Table 1). We determined
the baseline characteristics for household contacts,
stratified by age at <15 and >15 years (Table 2; Appendix Tables 1–4, https://wwwnc.cdc.gov/EID/
article/26/3/19-1314-App1.pdf).

M. tuberculosis Infection at Baseline and After
12 Months of Follow-up

Child contacts exposed to Beijing strains were more
likely than those exposed to non-Beijing strains to be
infected at baseline (risk ratio [RR] 1.27 [95% CI 1.06–
1.53]; adjusted RR [aRR] 1.23 [95% CI 1.02–1.50]) (Table 3) and by 12 months of follow-up (RR 1.20 [95% CI
1.08–1.35]; aRR 1.22 [95% CI 1.09-1.38]) (Table 4). The
prevalence of M. tuberculosis infection at baseline (RR
0.99 [95% CI 0.91–1.08]; aRR 1.00 [95% CI 0.91–1.09])
and by 12 months (RR 1.00 [95% CI 0.96–1.05]; aRR
1.01 [95% CI 0.97–1.06]) did not vary by index patient
M. tuberculosis strain in adult household contacts
(Tables 3, 4). In the sensitivity analyses, we obtained
almost identical results when we excluded household contacts who reported a history of TB, a previous positive TST result within 6 months after study
enrollment, or a history of TB treatment (Appendix
Tables 5, 6).
TST Conversion

The TST status of children exposed to Beijing strains
were more likely than that of children exposed to
other strains to convert from negative to positive during 12 months of follow-up in both the univariate and
Figure 1. Survival curves
for incident Mycobacterium
tuberculosis infection in child
household contacts by index
patient M. tuberculosis lineage,
Lima, Peru, September 2009–
August 2012.
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Figure 2. Survival curves
for incident Mycobacterium
tuberculosis infection in adult
household contacts by index
patient M. tuberculosis lineage,
Lima, Peru, September 2009–
August 2012.

multivariate analyses (hazard ratio [HR] 1.53 [95% CI
1.09–2.14]; adjusted HR [aHR] 1.65 [95% CI 1.17–2.33]).
Exposure to Beijing strains had no differential effect
in adults (HR 1.02 [95% CI 0.80–1.30]; aHR 1.03 [95%
CI 0.80–1.33]) (Table 5; Figures 1, 2). In the sensitivity
analyses, we defined TST conversion by an increment
of >6 mm in TST induration size during follow-up, and
the results changed by <5% (Appendix Table 7).
Progression to Active TB

After we adjusted for potential confounders, we found
the HR for TB among child contacts exposed to an index patient with Beijing strains compared with nonBeijing strains to be 1.45 (95% CI 0.77–2.7). We found
no evidence that exposure to Beijing strains affected
the risk for incident TB in adult contacts (aHR 1.06
[95% CI 0.64–1.77]) (Table 6; Figures 3, 4). The results

persisted when we restricted the analysis to household
contacts in whom TB was diagnosed within >30 days
after index patient diagnosis (Appendix Table 8).
Effect of Index Patient M. tuberculosis Lineage
on the Protective Efficacy of BCG Vaccine

Although they lacked statistical significance, the aRRs
for TB outcomes were higher for BCG-vaccinated
children exposed to Beijing strains than for non–BCGvaccinated children exposed to Beijing strains (aRR
1.01 [95% CI 0.69–1.49] for M. tuberculosis infection at
baseline; aRR 1.21 [95% CI 0.90–1.63] for infection by
12 months; aRR 1.84 [95% CI 0.77–4.39] for TST conversion; aRR 1.96 [95% CI 0.41–9.39] for incident TB).
This finding raises the possibility that BCG vaccination might be less efficacious in children exposed to
Beijing strains than in those exposed to other strains
Figure 3. Survival curves
for incident tuberculosis in
child household contacts by
index patient Mycobacterium
tuberculosis lineage, Lima, Peru,
September 2009–August 2012.
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Figure 4. Survival curves for
incident tuberculosis in adult
household contacts by index
patient Mycobacterium tuberculosis
lineage, Lima, Peru, September
2009–August 2012.

(Table 7). Among BCG-vaccinated adult household
contacts exposed to Beijing strains, the aRRs were
1.00 (95% CI 0.78–1.29) for M. tuberculosis infection at
baseline, 1.02 (95% CI 0.89–1.16) for infection by 12
months, 1.00 (95% CI 0.48–2.06) for TST conversion,
and 0.53 (95% CI 0.17–1.68) for incident TB (Table 7).
Discussion
In our study, children exposed to strains of M. tuberculosis Beijing sublineage were more likely than were
those exposed to strains of other lineages to become
infected. In addition, children exposed to Beijing
strains were more likely than children exposed to other strains to progress to TB, although the relative risk
of disease progression was not statistically significant
(type 1 error rate of 0.05). We did not observe these
effects among adult contacts.
Our results are consistent with those from previous studies that assessed the relative transmissibility
of the Beijing strain through cohort-based studies or
molecular epidemiology. In a study in South Africa,
Marais et al. found that children <5 years of age who
had household exposure to Beijing strains were 1.5
times more likely than those exposed to other strains to
be TST-positive at baseline (13). In a prospective cohort
study of household contacts in The Gambia, de Jong et
al. found that Beijing lineage–exposed contacts were 7
times more likely than those exposed to the M. africanum lineage to progress to TB after 2 years of follow-up
but were equally likely to be TST-positive at baseline
or convert at 3 months (12). In the De Jong et al. study,
the proportion of TST-positive household contacts at
baseline and the incidence of TST conversion and disease did not differ significantly between Beijing and
other strains within M. tuberculosis sensu strictu.
574

Although some molecular epidemiologic studies have found that Beijing strains are more likely
than other strains to form genotypic clusters, other
studies have not supported this conclusion. Many of
these studies assumed that patients within a chain of
recent M. tuberculosis transmission will share molecular fingerprints (32–36) and that clustering of genotypes is therefore a proxy for transmissibility and
disease progression. In China, Yang et al. reported
that patients infected with Beijing strains were 1.56
times more likely than those infected with other lineages to share molecular fingerprints with other patients (15). Similar findings have been reported from
Lima; in a study by Imawoto et al., 80% of Beijing
strains were in clusters, although clustering among
other strains was not reported (14). In Vietnam, Holt
et al. reported that, although the Beijing strains accounted for 58% of the total study sample, they constituted 70% of all clustered strains (21). In Papua
New Guinea, Bainomugisa et al. found that 82% of
isolates with Beijing strains were found in clusters,
compared with 43% of isolates with strains from
other lineages (37). In China, Yang et al. reported
that the proportions of clustering were 34% for Beijing and 18% for non-Beijing strains (38). However,
in Canada, Langlois-Klassen et al. found that Beijing
was less likely to be found in clusters than other
strains (21% vs. 37%) (16), and in the Netherlands,
Nebenzahl-Guimaraes et al. showed that Beijing
strains were no more transmissible than strains of
other lineages, after adjustment for host factors using an approach that controlled for the propensity of
a strain to propagate (17).
Some animal studies have provided evidence to
support the hypothesis that Beijing strains are more
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Table 7. Effects of BCG vaccination on M. tuberculosis infection and TB outcomes by lineage exposure for child and adult household
contacts of culture-positive pulmonary tuberculosis patients, Lima, Peru, September 2009–August 2012*
Non-Beijing lineage
Beijing lineage
Infection prevalence,
Infection prevalence,
Category and BCG vaccination status
no. (%)
RR (95% CI)
no. (%)
RR (95% CI)
p value
Children, <15 y
Baseline M. tuberculosis infection, n = 2,949
0.691
Without BCG vaccination
137 (27)
Referent
19 (32)
Referent
With BCG vaccination
552 (26)
0.94 (0.81–1.09)
83 (32)
1.01 (0.69–1.49)
M. tuberculosis infection by 12 months of follow-up, n = 2,417
0.405
Without BCG vaccination
187 (45)
Referent
26 (50)
Referent
With BCG vaccination
853 (50)
1.07 (0.97–1.19)
139 (60)
1.21 (0.90–1.63)
Incidence†
HR (95% CI)
Incidence†
HR (95% CI)
Time to TST conversion
0.579
Without BCG vaccination
0.18 (48/260)
Referent
0.21 (7/32)
Referent
With BCG vaccination
0.27 (292/1,065)
1.5 (1.08–2.08)
0.45 (53/119)
1.84 (0.77–4.39)
Time to TB
0.168
Without BCG vaccination
4,585 (25/545)
Referent
3,098 (2/65)
Referent
With BCG vaccination
2,619 (60/2291)
0.58 (0.35–0.96)
4,639 (13/280)
1.96 (0.41–9.39)
Infection prevalence,
Infection prevalence,
no. (%)
RR (95% CI)
no. (%)
RR (95% CI)
Adults, >15 y
Baseline M. tuberculosis infection, n = 5,381
0.611
Without BCG vaccination
260 (47)
Referent
27 (51)
Referent
With BCG vaccination
2,263 (54)
1.07 (0.98–1.18)
313 (54)
1.00 (0.78–1.29)
M. tuberculosis infection by 12 months of follow-up, n = 4,716
0.315
Without BCG vaccination
334 (72)
Referent
39 (81)
Referent
With BCG vaccination
3,042 (82)
1.10 (1.04–1.16)
419 (82)
1.02 (0.89–1.16)
Incidence†
HR (95% CI)
Incidence†
HR (95% CI)
Time to TST conversion
0.315
Without BCG vaccination
0.41 (70/172)
Referent
0.77 (10/13)
Referent
With BCG vaccination
0.72 (728/1,020)
1.55 (1.18–2.04)
0.73 (105/144)
1.00 (0.48–2.06)
Time to TB
0.732
Without BCG vaccination
4,813 (28/582)
Referent
6,574 (4/61)
Referent
With BCG vaccination
2,860 (129/4511)
0.66 (0.43–1.02)
2,434 (15/616)
0.53 (0.17–1.68)
*BCG, M. bovis BCG; HR, hazard ratio; RR, risk ratio; TB, tuberculosis; TST, tuberculin skin test.
†Cases per person-year (no. converted/no. tested).

likely than other lineages to cause disease. Mice experimentally infected with Beijing strains not only
died earlier and had higher death rates but also had
more lung tissue damage than controls (39–42). Some
in vitro studies of macrophages have also found that
the Beijing strain can downregulate the expression of
pathogen recognition receptors and major histocompatibility complex class II, modify the secretion of inflammatory cytokines, and induce the necrosis of host
immune cells (43–46).
We considered possible explanations for the difference in the effect of the Beijing strain in children
and adults. Given their mixing patterns, adults may
be more likely than children to be infected within the
community rather than in the household. If the household contacts in the cohort reported here had been
infected by someone other than the household index
patient, strain-specific exposure status might have
been misclassified. Such misclassification would have
been more likely in adults and would have biased
the results for this group toward the null of no effect.
However, another possibility is that Beijing strains
might lead to earlier disease progression in younger

persons with newly acquired M. tuberculosis. Several
studies from Vietnam report that Beijing strains make
up the highest proportion of incident cases in persons
<20 years of age and that the prevalence of Beijing
strains declines with increasing age (18,19). In Iran,
Erie et al. similarly showed that 27% of patients <20
years of age were infected by Beijing strains and that
the prevalence of Beijing strains among patients >20
years of age was 13% (20). The increasing prevalence
of Beijing strains in children may be related to use of
BCG vaccine. This explanation would be consistent
with our finding that that the protective efficacy of
BCG vaccine against Beijing strains was reduced in
children but not in adults. Possible explanations for
these observations include a decrease in the protective efficacy of BCG vaccination with increasing age,
a shift in the administered BCG strain in Peru’s recent
history, or a reduction in the immunogenicity of BCG
vaccine over time (47–49).
Our study had several notable limitations. First,
within a high-transmission setting such as Lima,
children still could have been infected outside the
household. Misclassification of the lineage exposure
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status in children also would have led to an underestimation of the effect. Second, discrepancies between 24-locus MIRU-VNTR genotyping and WGS
have been noted previously (50), and some lineages
assigned on the basis of MIRU-VNTR could have
been inaccurate, again leading to a misclassification
error that could have underestimated the true effect
of Beijing strains.
In conclusion, we found that exposure to household index patients infected with Beijing strains was
associated with increased risk for TST conversion and
disease in children <15 years of age but not in adults.
These findings raise the possibility that genotypic
variation in M. tuberculosis may have important phenotypic effects that should be further studied. In particular, it will be essential to determine whether BCG
vaccination provides less protection against Beijing
strains than strains from other lineages and whether
the efficacy of any newly developed vaccines varies
by M. tuberculosis genoype.
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Mycobacterium tuberculosis Beijing
Lineage and Risk for Tuberculosis in Child
Household Contacts, Peru
Appendix
Appendix Table 1. Baseline characteristics of child household contacts by baseline Mycobacterium tuberculosis infection status
Variable
Uninfected, no. (%)*
Infected, no. (%)*
p value†
Age, y
0–5
1,066 (47)
286 (34)
<0.001
6–10
644 (28)
262 (31)
11–15
564 (25)
293 (35)
Sex, M
1,159 (51)
407 (48)
0.211
HIV seropositive
3 (<1)
0
0.568
Self-reported diabetes
1 (<)
1 (<1)
0.465
Current smoker
2 (<1)
2 (<1)
0.296
M. tuberculosis lineage exposure
L2 (Beijing)
223 (10)
110 (13)
<0.001
L4.1
912 (40)
382 (45)
L4.3
891 (39)
272 (32)
Other
248 (11)
77 (9)
Presence of M. bovis BCG scar
1,847 (81)
675 (80)
0.538
Nutritional status
Normal weight
1775 (79)
667 (80)
0.178
Underweight
71 (3)
16 (2)
Overweight
399 (18)
151 (18)
Socioeconomic status
Low
846 (38)
350 (43)
0.038
Middle
1,012 (45)
336 (41)
High
373 (17)
127 (16)
Isoniazid preventive therapy recipient
1,193 (52)
437 (52)
0.809
*Total number varied because of missing data.
†χ-square test p value.
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Appendix Table 2. Baseline characteristics of adult household contacts by baseline Mycobacterium tuberculosis infection status
Variable
Uninfected, no. (%)*
Infected, no. (%)*
p value†
Age, y
16–30
1,263 (48)
1,097 (36)
0.001
682 (26)
871 (29)
31–45
46–60
413 (16)
717 (24)
>60
298 (11)
322 (11)
Sex, M
1,122 (42)
1,288 (43)
0.674
HIV seropositive
7 (<1)
19 (1)
0.067
Self-reported diabetes
63 (2)
93 (3)
0.11
Current smoker
219 (8)
304 (10)
0.015
M. tuberculosis lineage exposure
L2 (Beijing)
309 (12)
353 (12)
0.574
L4.1
1,050 (40)
1,240 (41)
L4.3
1,015 (38)
1,108 (37)
Other
282 (11)
306 (10)
Presence of M. bovis BCG scar
2,321 (87)
2,704 (90)
0.003
Nutritional status
Normal weight
1,337 (51)
1,276 (43)
0.001
Underweight
23 (1)
42 (1)
Overweight
1,272 (48)
1,664 (56)
Socioeconomic status
Low
781 (30)
1,001 (34)
0.007
Middle
1,214 (47)
1,289 (44)
High
594 (23)
646 (22)
Isoniazid preventive therapy recipient
224 (8)
169 (6)
0.001
*

Total number varied because of missing data.
†χ-square test p value.

Appendix Table 3. Baseline characteristics of child household contacts by incident tuberculosis status
Variable
Disease free, no. (%)*
Secondary tuberculosis, no. (%)*
Age, y
0–5
1,350 (44)
57 (40)
6–10
898 (29)
33 (33)
11–15
834 (27)
53 (37)
Sex, M
1,545 (50)
75 (52)
HIV seropositive
3 (<1)
0
Self-reported diabetes
2 (<1)
0
Current smoker
4 (<1)
0
Presence of Mycobacterium bovis BCG scar
2,498 (81)
112 (87)
Nutritional status
Normal weight
2,404 (79)
123 (87)
Underweight
93 (3)
2 (1)
Overweight
548 (18)
17 (12)
Socioeconomic status
Low
1,192 (40)
61 (44)
Middle
1,325 (44)
59 (42)
High
494 (16)
20 (14)
Isoniazid preventive therapy recipient
1,641 (53)
40 (28)
*

Total number varied because of missing data.
†χ-square test p value.
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p value†
0.027

0.648
0.999
0.999
0.999
0.477
0.081

0.604

<0.001

Appendix Table 4. Baseline characteristics of adult household contacts by incident tuberculosis status
Variable
Disease free, no. (%)*
Secondary tuberculosis, no. (%)*
Age, y
16–30
2,304 (41)
153 (53)
31–45
1,560 (28)
61 (21)
46–60
1,137 (20)
46 (16)
>60
619 (11)
30 (10)
Sex, M
2,356 (42)
159 (55)
HIV seropositive
26 (<1)
4 (1)
Self-reported diabetes
153 (3)
9 (3)
Current smoker
524 (9)
26 (9)
Presence of Mycobacterium bovis BCG scar
4,991(89)
247 (85)
Nutritional status
Normal weight
2,536 (46)
190 (66)
Underweight
55 (1)
13 (5)
Overweight
2,979 (53)
84 (29)
Socioeconomic status
Low
1,749 (32)
106 (37)
Middle
2,473 (45)
122 (43)
High
1,259 (23)
55 (19)
Isoniazid preventive therapy recipient
403 (7)
6 (2)

p value†
0.001

<0.001
0.086
0.838
0.91
0.067
<0.001

0.117

<0.001

*

Total number varied because of missing data.
†χ-square test p value.

Appendix Table 5. Effect of the Mycobacterium tuberculosis Beijing lineage on the risk for tuberculin skin test positivity at baseline
in child and adult household contacts*
Age <15 y, n = 2,981
Age >15 y, n = 4,968
Rate ratio (95% CI)
Prevalence of
Rate ratio (95%CI)
Prevalence of
infection, no.
Lineage
infection, no. (%)†
Univariate
Multivariate‡
(%)†
Univariate
Multivariate‡
Non-Beijing
619 (23)
Referent
Referent
2,022 (46)
Referent
Referent
Beijing
88 (28)
1.27 (1.06–1.53) 1.22 (0.99–1.52)
290 (48)
1.03 (0.94–1.14) 1.03 (0.93–1.14)
Excludes household contacts with history of tuberculosis, history of previous positive tuberculin skin test, or history of tuberculosis treatment.
†Prevalence of baseline M. tuberculosis infection univariate model.
‡Multivariate model adjusted for index patient drug resistance profile; index patient age (16–30, 31–45, 46–60, and >60 y); index patient HIV status;
household contact age (0–5, 6–10, 11–15, 16–30, 31–45, 46–60, and >60 y); household contact M. bovis BCG status; household contact
socioeconomic status; household contact nutritional status.

Appendix Table 6. Effect of the Mycobacterium tuberculosis Beijing lineage on the risk for tuberculin skin test positivity by 12
months of follow-up in child and adult household contacts*
Age <5 y, n = 2,387
>15 Years (n = 4,716)
Prevalence of
Risk ratio (95% CI)
Prevalence of
Risk ratio (95% CI)
infection, no.
infection, no.
Lineage
(%)†
Univariate
Multivariate‡
(%)†
Univariate
Multivariate‡
Non-Beijing
986 (47)
Referent
Referent
2,914 (79)
Referent
Referent
Beijing
88 (56)
1.21 (1.07–1.37) 1.23 (1.08–1.41)
411 (80)
1.03 (0.94–1.14) 1.02 (0.97–1.08)
*Excludes household contacts with history of tuberculosis, history of previous positive tuberculin skin test, or history of tuberculosis.
†Prevalence of M. tuberculosis infection at 12 months for the univariate model.
‡Multivariate model adjusted for index patient drug resistance profile; index patient age (16–30, 31–45, 46–60, and >60 y); index patient HIV status;
household contact age (0–5, 6–10, 11–15, 16–30, 31–45, 46–60, and >60 y); household contact M. bovis BCG status; household contact
socioeconomic status; household contact nutritional status.

Appendix Table 7. Comparison of hazard ratios for tuberculin skin test conversion between household contacts exposed to
Mycobacterium tuberculosis Beijing lineage and non-Beijing lineage*
Age <5 y
Age >15 y
Hazard ratio (95% CI)
Hazard ratio (95% CI)
Lineage
Incidence†
Univariate
Multivariate‡
Incidence†
Univariate
Multivariate‡
Non-Beijing 0.32 (370/1,162)
Referent
Referent
0.69 (749/1,084)
Referent
Referent
Beijing
0.47 (62/132)
1.46 (1.05–2.02) 1.63 (1.16–2.28)
0.73 (105/142)
1.04 (0.83–1.32 1.07 (0.84–1.36)
*>6 mm increment in tuberculin skin test induration size.
†Cases per person-year for the univariate model.
‡Multivariate model adjusted for index patient drug resistance profile; index patient age (16–30, 31–45, 46–60, and >60 y); index patient HIV status;
household contact age (0–5, 6–10, 11–15, 16–30, 31–45, 46–60, and >60 y); household contact M. bovis BCG status; household contact
socioeconomic status; household contact nutritional status.

Page 3 of 4

Appendix Table 8. Comparison of hazard ratios for incident tuberculosis* between contacts exposed to Mycobacterium tuberculosis
Beijing lineage and non-Beijing lineage
Age <15 y
Age >15 y
Hazard ratio
Hazard ratio (95% CI)
(95% CI)
Lineage
Incidence†
Univariate
Multivariate‡
Incidence†
Univariate
Multivariate‡
Non-Beijing 2,151 (61/2,836)
Referent
Referent
2,264 (113/4,991)
Referent
Referent
Beijing
3,478 (12/345) 1.57 (0.41–6.00) 1.48 (0.74–2.95)
2,118 (14/661)
0.92 (0.52–1.65) 1.02 (0.56–1.88)
*Tuberculosis diagnosed >30 days after the diagnosis in the index patient.
†Cases per 100,000 person-year for the univariate model.
‡Multivariate model adjusted for index patient drug resistance profile; index patient age (16–30, 31–45, 46–60, and >60 y); index patient HIV status;
household contact age (0–5, 6–10, 11–15, 16–30, 31–45, 46–60, and >60 y); household contact M. bovis BCG status; household contact
socioeconomic status; household contact nutritional status; household contact use of Isoniazid preventive therapy; household contact tuberculosis
history.

Appendix Table 9. Mycobacterium bovis BCG status among household contacts of culture-positive index patients, by nutritional
status and socioeconomic status
Variable
Non-BCG recipients, no. (%)
BCG recipients, no. (%)
p value*
Child contacts
Nutritional status
Normal weight
488 (81)
2,038 (79)
0.536
Underweight
16 (3)
79 (3)
Overweight
99 (16)
466 (18)
Socioeconomic status
Low
241 (40)
1,012 (40)
0.237
Middle
273 (46)
1,111 (44)
High
84 (14)
430 (17)
Adult contacts
Nutritional status
Normal weight
385 (58)
2,348 (45)
<0.001
Underweight
16 (2)
52 (1)
Overweight
265 (40)
2,805 (54)
Socioeconomic status
Low
208 (32)
1,649 (32)
0.6
Middle
304 (47)
2,303 (45)
High
139 (21)
1,174 (23)
*χ-square test p value.
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